Naoki Amada

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsBehavioural epidemiologyMajor global burdens of diseaseToxicology (incl. clinical toxicology)Foetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Clobazam and Valproate, but Lamotrigine, a Sodium Channel Inhibitor, Reduce the Incidence of Hyperthermia-Induced Clonic Seizures in Dravet Syndrome Mice: Assessment of Anti-Seizure Effects in Mice Using a Stabilized Ambient Temperature System.

|Mar 07, 2026
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in Rats.

Naoki Amada, Mai Nakamura, Yuta Ohgi

|Jun 26, 2024
Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse models.

Naoki Amada, Shinji Sato, Dai Ishikawa

|Jan 17, 2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.

Naoki Amada, Tsuyoshi Hirose, Mikio Suzuki

|May 03, 2022
Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy.

Naoki Amada, Yusuke Kakumoto, Takashi Futamura

|Sep 06, 2019
Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats.

Naoki Amada, Hitomi Akazawa, Yuta Ohgi

Pageof 1

Frequent Collaborators

1 joint publications

Tetsuro Kikuchi

1 joint publications

Futa Sato

1 joint publications

Megumi Oishi

1 joint publications

Yuki Matsuo